Skip to main content
EJNMMI Reports

Table 1 Patient characteristics (n = 58)

From: Prognostic analysis of curatively resected pancreatic cancer using harmonized positron emission tomography radiomic features

Age, mean ± SD (range), year

69.2 ± 10.9 (34–86)

Tumour location, n

 

 Head/body/tail

39/4/15

Pathological stage (UICC 8th edition), n

 

 T2/T3

42/16

 N0/N1/N2

17/19/22

 Stage IB/IIA/IIB/III

12/5/19/22

Histology, n

 

 Adenocarcinoma/adenosquamous/anaplastic

55/2/1

Surgery, n

 

 SSPPD/DP/TP

38/17/3

 Neural invasion (pos/neg)

49/9

Adjuvant chemotherapy, n

 

 TS-1/GEM/incomplete

19/4/35

  1. DP distal pancreatectomy, GEM gemcitabine, S-1 TS-1 (Tegafur, Gimeracil, Oteracil Potassium), SSPPD subtotal stomach-preserving pancreaticoduodenectomy, TP total pancreatectomy, UICC Union for International Cancer Control
Back to article page